Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Coagulation inhibitor replacement during sepsis: useless?

J N Hoffman1, E Faist

  • 1Department of Surgery, Klinikum Grosshadern, Ludwig-Maximilians University, Munich, Germany.

Critical Care Medicine
|September 28, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Design and evaluation of the University of Munich courses on research trials].

Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen·2008
Same author

Depressed T cell-derived IFN-gamma following trauma-hemorrhage: a potential mechanism for diminished APC responses.

Langenbeck's archives of surgery·2007
Same author

Immunomodulation during sepsis in organ transplanted children.

Minerva pediatrica·2005
Same author

Differences in the expression of LPS-receptors are not responsible for the sex-specific immune response after trauma and hemorrhagic shock.

Cellular immunology·2004
Same author

[Inflammatory syndrome after endovascular implantation of an aortic stent--a comparative study].

Langenbecks Archiv fur Chirurgie. Supplement. Kongressband. Deutsche Gesellschaft fur Chirurgie. Kongress·2003
Same author

Effects of perioperative recombinant human IFN-gamma (rHuIFN-gamma) application in vivo on T cell response.

Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research·2003
Same journal

The authors reply.

Critical care medicine·2026
Same journal

Attracting Emergency Medicine Graduates to Surgical Critical Care Training Programs.

Critical care medicine·2026
Same journal

The authors reply.

Critical care medicine·2026
Same journal

Beyond a Snapshot: Tracking Family Prognostic Expectations in the ICU.

Critical care medicine·2026
Same journal

The authors reply.

Critical care medicine·2026
Same journal

Plasma Levels of Soluble ST2 Reflect Extrapulmonary Organ Dysfunction and Predict Outcomes in Acute Respiratory Failure: Beware of Potential Confounders.

Critical care medicine·2026
See all related articles

Sepsis-induced coagulation activation is complex; direct thrombin inhibition may not benefit all patients. Targeting inflammatory mediators and using natural inhibitors like antithrombin may improve outcomes.

Area of Science:

  • Sepsis Pathophysiology
  • Coagulation Cascade
  • Pharmacological Interventions

Background:

  • Sepsis involves coagulation activation, primarily from tissue factor release.
  • This activation is mediated by proinflammatory cytokines affecting endothelial cells and monocytes.
  • Exogenous coagulation inhibitors are explored to prevent sepsis-induced organ dysfunction.

Purpose of the Study:

  • To review the role of coagulation inhibitors in sepsis.
  • To evaluate the potential benefits and risks of inhibiting the coagulation cascade in sepsis patients.
  • To explore alternative therapeutic targets for sepsis-induced organ dysfunction.

Main Methods:

  • A comprehensive literature review was conducted.
  • Clinical and experimental studies on coagulation inhibitors in sepsis were analyzed.

Related Experiment Videos

Main Results:

  • The protective role of coagulation during sepsis is not fully understood.
  • Widespread fibrin deposition is not consistently observed in sepsis patients with multiple organ dysfunction syndrome.
  • Coagulation activation may not directly cause organ dysfunction but contributes to endothelial activation and inflammation.

Conclusions:

  • Caution is advised when administering coagulation inhibitors in sepsis.
  • Targeting inflammatory mediators and endothelial activation may be more beneficial.
  • Natural coagulation inhibitors with positive microcirculatory effects, such as activated protein C and antithrombin, show promise.